Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 338

1.

Residual risk of HIV, HVB and HCV transmission by blood transfusion between 2002 and 2004 at the Abidjan National Blood Transfusion Center.

Ouattara H, Siransy-Bogui L, Fretz C, Diane KM, Konate S, Koidio A, Minga KA, Hyda J, Koffi-Abe N, Offoumou AM, Abissey S.

Transfus Clin Biol. 2006 Oct;13(4):242-5. Epub 2006 Jul 5.

PMID:
16822686
2.

[Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].

Pillonel J, Laperche S; Groupe "Agents Transmissibles par Transfusion" de la Société française de transfusion sanguine; Etablissement français du sang; Centre de transfusion sanguine des armées.

Transfus Clin Biol. 2004 Apr;11(2):81-6. French.

PMID:
15120104
3.

The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria.

Whyte GS, Savoia HF.

Med J Aust. 1997 Jun 2;166(11):584-6.

PMID:
9201178
4.

Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.

Weusten JJ, van Drimmelen HA, Lelie PN.

Transfusion. 2002 May;42(5):537-48.

PMID:
12084161
5.

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.

Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.

Transfusion. 2009 Jun;49(6):1115-25. doi: 10.1111/j.1537-2995.2009.02110.x. Epub 2009 Feb 27.

PMID:
19309474
6.

Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.

Gonzalez M, Règine V, Piccinini V, Vulcano F, Giampaolo A, Hassan HJ.

Transfusion. 2005 Oct;45(10):1670-5.

PMID:
16181219
9.

The risk of transfusion-transmitted infections in sub-Saharan Africa.

Jayaraman S, Chalabi Z, Perel P, Guerriero C, Roberts I.

Transfusion. 2010 Feb;50(2):433-42. doi: 10.1111/j.1537-2995.2009.002402.x. Epub 2009 Oct 15. Review.

PMID:
19843290
10.
11.

Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.

O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC.

Transfusion. 2007 Feb;47(2):316-25.

PMID:
17302779
12.

Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.

Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hone DE, O'Brien SF, Sher G.

CMAJ. 2003 Oct 14;169(8):767-73.

13.
14.

Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.

Seed CR, Cheng A, Ismay SL, Bolton WV, Kiely P, Cobain TJ, Keller AJ; Virology Subcommittee of the National Donor and Product Safety Committee, Australian Red Cross Blood Service.

Transfusion. 2002 Oct;42(10):1365-72.

PMID:
12423522
15.

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.

Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ; German Red Cross NAT Study Group.

Transfusion. 2008 Aug;48(8):1558-66. doi: 10.1111/j.1537-2995.2008.01718.x. Epub 2008 May 6.

PMID:
18466173
16.

Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.

O'Brien SF, Yi QL, Fan W, Scalia V, Fearon MA, Allain JP.

Vox Sang. 2012 Jul;103(1):83-6. doi: 10.1111/j.1423-0410.2012.01584.x. Epub 2012 Jan 31.

PMID:
22289147
17.

Residual risk of transfusion-transmitted viral infections in Spain, 1997-2002, and impact of nucleic acid testing.

Alvarez do Barrio M, González Díez R, Hernández Sánchez JM, Oyonarte Gómez S.

Euro Surveill. 2005 Feb;10(2):20-2.

PMID:
15735311
18.

Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy.

Velati C, Romanò L, Baruffi L, Pappalettera M, Carreri V, Zanetti AR.

Transfusion. 2002 Aug;42(8):989-93.

PMID:
12385408
19.

Safety of blood supply in the Caribbean countries: role of screening blood donors for markers of hepatitis B and C viruses.

Cruz JR, Pérez-Rosales MD, Zicker F, Schmunis GA.

J Clin Virol. 2005 Dec;34 Suppl 2:S75-80.

PMID:
16461244
20.

[Evaluation of residual infectious risk among blood donors in National Center of Blood Transfusion in Conakry].

Loua A, Sow EM, Magassouba FB, Camara M, Baldé MA.

Transfus Clin Biol. 2004 Apr;11(2):98-100. French.

PMID:
15120107

Supplemental Content

Support Center